These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28005594)

  • 1. Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy.
    Barton JR; Sibai BM
    Clin Obstet Gynecol; 2017 Mar; 60(1):198-205. PubMed ID: 28005594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
    S D; Novri DA; Hamidy Y; Savira M
    F1000Res; 2022; 11():1287. PubMed ID: 37273965
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
    Kausar M; Husain S; Hussain R
    Afr Health Sci; 2023 Mar; 23(1):320-325. PubMed ID: 37545898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypertension in pregnancy.
    Wiles K; Damodaram M; Frise C
    Clin Med (Lond); 2021 Sep; 21(5):e451-e456. PubMed ID: 34507929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia.
    Obstet Gynecol; 2011 Dec; 118(6):1465-1468. PubMed ID: 22105295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe pre-eclampsia and hypertensive crises.
    Arulkumaran N; Lightstone L
    Best Pract Res Clin Obstet Gynaecol; 2013 Dec; 27(6):877-84. PubMed ID: 23962474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
    Muhammad S; Usman H; Dawha YM; Yahya A; Yekeen A; Bako B
    Pregnancy Hypertens; 2022 Aug; 29():1-6. PubMed ID: 35605426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive emergencies of pregnancy.
    Alexander JM; Wilson KL
    Obstet Gynecol Clin North Am; 2013 Mar; 40(1):89-101. PubMed ID: 23466139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and Current Clinical Management of Preeclampsia.
    Amaral LM; Wallace K; Owens M; LaMarca B
    Curr Hypertens Rep; 2017 Aug; 19(8):61. PubMed ID: 28689331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia.
    Aali BS; Nejad SS
    Acta Obstet Gynecol Scand; 2002 Jan; 81(1):25-30. PubMed ID: 11942883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertensive emergencies in pregnancy.
    Vadhera RB; Simon M
    Clin Obstet Gynecol; 2014 Dec; 57(4):797-805. PubMed ID: 25314092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focused Update on Pharmacologic Management of Hypertensive Emergencies.
    Watson K; Broscious R; Devabhakthuni S; Noel ZR
    Curr Hypertens Rep; 2018 Jun; 20(7):56. PubMed ID: 29884955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
    Baggio MR; Martins WP; Calderon AC; Berezowski AT; Marcolin AC; Duarte G; Cavalli RC
    Ultrasound Med Biol; 2011 Jan; 37(1):53-8. PubMed ID: 21084154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
    Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
    Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.